Literature DB >> 28567195

Abdominal myomectomy: A retrospective review of determinants and outcomes of complications at the University of Ilorin Teaching Hospital, Ilorin, Nigeria.

Kikelomo T Adesina1,2, Beatrice O Owolabi2, Hadijat O Raji1,2, Adebunmi O Olarinoye1,2.   

Abstract

BACKGROUND: The aim of this study was to describe the pattern, outcomes, and determinants of perioperative complications of abdominal myomectomy at the University of Ilorin Teaching Hospital, Ilorin, Nigeria.
METHODS: This was a retrospective review of cases of abdominal myomectomy between January 2010 and December 2013. Data were obtained from ward and operating theatre case records and analysed using SPSS version 20. The continuous variables were analysed with Student's t-test. The categorical variables were analysed with the chi-square test. P-values of 0.05 or less was taken to be significant.
RESULTS: Total sampling yielded 204 cases, of which 170 records (80%) were adequate for analysis. Using criteria developed by Garry et al., major and minor complications occurred in 43.6% and 32.9% of procedures, respectively, while 23.5% of the patients had no complications. The commonest complication was intraoperative haemorrhage requiring blood transfusion. Mean estimated blood loss was 630.88 ± 392.42 mL. There were no cases converted to hysterectomy, and no deaths were recorded. Uterine size equivalent to 16 weeks' gestation or more was significantly associated with heavier blood loss, blood transfusion, and fever (P = 0.034). Other significant determinants of major intraoperative haemorrhage with or without blood transfusion were menstrual flow of 6 days or more, preoperative anaemia, previous surgery, posterior incision, and surgery duration longer than 4 hours (P < 0.05).
CONCLUSIONS: Outcome of abdominal myomectomy is generally favourable even if uterine size is greater than 16 weeks by palpation. Nevertheless, patients should be counselled preoperatively on the risk of blood loss and the possibility of blood transfusion.

Entities:  

Mesh:

Year:  2017        PMID: 28567195      PMCID: PMC5442490          DOI: 10.4314/mmj.v29i1.8

Source DB:  PubMed          Journal:  Malawi Med J        ISSN: 1995-7262            Impact factor:   0.875


  23 in total

1.  Uterine fibroid: clinical presentation and relative morbidity of abdominal myomectomy and total abdominal hysterectomy, in a teaching hospital of Karachi, Pakistan.

Authors:  Nuruddin B Mohammed; Rozina NoorAli; Chinnaiya AnandaKumar
Journal:  Singapore Med J       Date:  2002-06       Impact factor: 1.858

2.  Uterine Leiomyomata in South Western Nigeria: a clinical study of presentations and management outcome.

Authors:  F O Okogbo; O C Ezechi; O M Loto; P M Ezeobi
Journal:  Afr Health Sci       Date:  2011-06       Impact factor: 0.927

3.  Comparability of perioperative morbidity between abdominal myomectomy and hysterectomy for women with uterine leiomyomas.

Authors:  S W Sawin; N D Pilevsky; J A Berlin; K T Barnhart
Journal:  Am J Obstet Gynecol       Date:  2000-12       Impact factor: 8.661

4.  Why is parity protective for uterine fibroids?

Authors:  Donna Day Baird; David B Dunson
Journal:  Epidemiology       Date:  2003-03       Impact factor: 4.822

5.  The effect of anastrazole on symptomatic uterine leiomyomata.

Authors:  Fotios K Varelas; Alexis N Papanicolaou; Norma Vavatsi-Christaki; Georgios A Makedos; Georgios D Vlassis
Journal:  Obstet Gynecol       Date:  2007-09       Impact factor: 7.661

6.  Risk factors for clinically diagnosed uterine fibroids in women around menopause.

Authors:  Fabio Parazzini
Journal:  Maturitas       Date:  2006-03-13       Impact factor: 4.342

7.  Evaluation of perioperative morbidity associated with single and multiple myomectomy.

Authors:  K Kunde; E Cortes; P Seed; Y Khalaf
Journal:  J Obstet Gynaecol       Date:  2009-11       Impact factor: 1.246

8.  Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study.

Authors:  Lauren A Wise; Julie R Palmer; Bernard L Harlow; Donna Spiegelman; Elizabeth A Stewart; Lucile L Adams-Campbell; Lynn Rosenberg
Journal:  Am J Epidemiol       Date:  2004-01-15       Impact factor: 4.897

9.  The eVALuate study: two parallel randomised trials, one comparing laparoscopic with abdominal hysterectomy, the other comparing laparoscopic with vaginal hysterectomy.

Authors:  Ray Garry; Jayne Fountain; Su Mason; Jeremy Hawe; Vicky Napp; Jason Abbott; Richard Clayton; Graham Phillips; Mark Whittaker; Richard Lilford; Stephen Bridgman; Julia Brown
Journal:  BMJ       Date:  2004-01-07

10.  Mifepristone for the treatment of uterine leiomyomas: a randomized controlled trial.

Authors:  Josep Lluis Carbonell Esteve; Rita Acosta; Braulio Heredia; Yasmiriam Pérez; Maria C Yero Castañeda; Aleta Valle Hernández
Journal:  Obstet Gynecol       Date:  2008-11       Impact factor: 7.661

View more
  3 in total

1.  Burden of Uterine Fibroids: An African Perspective, A Call for Action and Opportunity for Intervention.

Authors:  P Igboeli; W Walker; A McHugh; A Sultan; A Al-Hendy
Journal:  Curr Opin Gynecol Obstet       Date:  2019-08-11

2.  Comparing perioperative vaginal misoprostol with intraoperative pericervical hemostatic tourniquet in reducing blood loss during abdominal myomectomy: A randomized controlled trial

Authors:  Muhibat A. Afolabi; Grace G. Ezeoke; Rakiya Saidu; Munirdeen A. Ijaiya; Abiodun S. Adeniran
Journal:  J Turk Ger Gynecol Assoc       Date:  2018-11-30

3.  Uterine Fibroids in Black Women: A Race-Stratified Subgroup Analysis of Treatment Outcomes After Laparoscopic Radiofrequency Ablation.

Authors:  Jay M Berman; Linda Bradley; Soyini M Hawkins; Barbara Levy
Journal:  J Womens Health (Larchmt)       Date:  2021-07-20       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.